Mireille N M van Poppel Selected Research

Gestational Weight Gain

1/2022	Interaction between rs10830962 polymorphism in MTNR1B and lifestyle intervention on maternal and neonatal outcomes: secondary analyses of the DALI lifestyle randomized controlled trial.
1/2020	A core outcome set for studies of gestational diabetes mellitus prevention and treatment.
12/2019	The association of human milk oligosaccharides with glucose metabolism in overweight and obese pregnant women.
1/2019	A reduction in sedentary behaviour in obese women during pregnancy reduces neonatal adiposity: the DALI randomised controlled trial.
1/2018	Angiopoietin-like protein 4 (ANGPTL4) is related to gestational weight gain in pregnant women with obesity.
1/2018	Cost-effectiveness of healthy eating and/or physical activity promotion in pregnant women at increased risk of gestational diabetes mellitus: economic evaluation alongside the DALI study, a European multicenter randomized controlled trial.
7/2013	DALI: Vitamin D and lifestyle intervention for gestational diabetes mellitus (GDM) prevention: an European multicentre, randomised trial - study protocol.
1/2009	Design of FitFor2 study: the effects of an exercise program on insulin sensitivity and plasma glucose levels in pregnant women at high risk for gestational diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mireille N M van Poppel Research Topics

Disease

19	Insulin Resistance 03/2022 - 01/2009
18	Gestational Diabetes (Gestational Diabetes Mellitus) 02/2022 - 01/2009
8	Overweight 02/2022 - 07/2013
8	Gestational Weight Gain 01/2022 - 01/2009
5	Birth Weight (Birth Weights) 01/2020 - 07/2012
3	Obesity 01/2020 - 01/2014
2	Maternal Obesity 09/2021 - 01/2020
2	Stillbirth 01/2020 - 07/2018
2	Premature Birth (Birth, Premature) 01/2020 - 09/2019
2	Weight Gain 01/2020 - 01/2018
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 05/2012 - 01/2012
2	Low Back Pain (Lumbago) 12/2010 - 11/2007
1	Vitamin D Deficiency 01/2020
1	Perinatal Death 01/2020
1	Type 2 Diabetes Mellitus (MODY) 11/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2019
1	Postpartum Depression (Post-Natal Depression) 11/2019
1	Glucose Intolerance 11/2019
1	Neural Tube Defects (Exencephaly) 05/2014
1	Inflammation (Inflammations) 01/2014
1	Pain (Aches) 12/2012
1	Constipation 07/2006
1	Hypercholesterolemia 10/2005
1	Hypertension (High Blood Pressure) 10/2005

Drug/Important Bio-Agent (IBA)

19	Glucose (Dextrose)FDA LinkGeneric 02/2022 - 01/2009
11	Insulin (Novolin)FDA Link 03/2022 - 10/2005
10	Vitamin D FDA LinkGeneric 01/2021 - 07/2013
6	LeptinIBA 01/2022 - 01/2015
3	C-PeptideIBA 01/2022 - 01/2020
3	CytokinesIBA 12/2016 - 04/2014
2	OligosaccharidesIBA 11/2021 - 12/2019
2	Triglycerides (Triacylglycerol)IBA 07/2013 - 01/2009
1	MicroRNAs (MicroRNA)IBA 02/2022
1	Melatonin Receptors (Melatonin Receptor)IBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 09/2021
1	CotinineIBA 09/2021
1	HexokinaseIBA 09/2021
1	hydroxide ionIBA 01/2020
1	Angiopoietin-Like Protein 4IBA 01/2018
1	Linoleic Acid (Linoleate)IBA 01/2018
1	LipidsIBA 12/2016
1	AdiponectinIBA 01/2016
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2015
1	Insulin-Like Growth Factor Binding Protein 3IBA 01/2015
1	Insulin-Like PeptidesIBA 01/2015
1	Folic Acid (Vitamin M)FDA LinkGeneric 05/2014
1	InterleukinsIBA 04/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2014
1	C-Reactive ProteinIBA 04/2014
1	Interleukin-10 (Interleukin 10)IBA 04/2014
1	Interleukin-6 (Interleukin 6)IBA 04/2014
1	AdipokinesIBA 01/2014
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 07/2013
1	Blood Glucose (Blood Sugar)IBA 07/2012
1	LDL CholesterolIBA 05/2012
1	oxidized low density lipoproteinIBA 05/2012
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2012
1	HDL CholesterolIBA 01/2009

Therapy/Procedure

2	Therapeutics 01/2020 - 01/2012
2	Cesarean Section (Caesarean Section) 09/2019 - 10/2018
2	Secondary Prevention 12/2010 - 11/2007
1	Bed Rest (Bedrest) 12/2012
1	Long-Term Care 07/2006